George Simeon Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
7
Insider Buys Sum
$44.44M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of George Simeon

According to the SEC Form 4 filings, George Simeon, being in a position of

  1. director at CRISPR Therapeutics AG,
    оver the last 12 months, has bought 0 shares, and sold 14514 shares for $720,373,
    over all time since 2016-10-24, has bought 1122812 shares for $53.36M, and sold 14514 shares for $720,373.

Biography of George Simeon

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$720,3731100

Comparison of Insiders on Amount of Buys and Sells

2026-10-14SaleCRISPR Therapeutics AG
CRSP
director
14,514
0.0148%
$49.63$720,373-0.41%
2025-07-16PurchaseCRISPR Therapeutics AG
CRSP
director
989,812
1.0815%
$52.03$51.5M-0.56%
2024-03-27PurchaseNkarta, Inc.
NKTX
director
2M
3.6511%
$10.00$20M-58.16%
2022-12-20PurchaseDesign Therapeutics, Inc.
DSGN
director
40,000
0.0725%
$8.14$325,432-27.67%
2022-12-19PurchaseDesign Therapeutics, Inc.
DSGN
director
360,000
0.6698%
$8.63$3.11M-29.29%
2022-12-16PurchaseDesign Therapeutics, Inc.
DSGN
director
500,000
0.8485%
$8.28$4.14M-32.02%
2022-04-28PurchaseNkarta, Inc.
NKTX
666,667
1.2658%
$15.00$10M-32.41%
2021-03-30PurchaseDesign Therapeutics, Inc.
DSGN
250,000
0.9607%
$20.00$5M-40.99%
2016-10-24PurchaseCRISPR Therapeutics AG
CRSP
director
133,000
1.0843%
$14.00$1.86M+31.44%
Total: 9
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.